Pharmaceutical - AstraZeneca

Filter

Current filters:

AstraZeneca

Popular Filters

151 to 175 of 313 results

UK's NICE backs NHS use of Bristol-Myers/AstraZeneca's Forxiga

30-05-2013

UK drugs watchdog the National Institute for Health and Care Excellence (NICE) today (May 30) issued…

AstraZenecaBristol-Myers SquibbDiabetesEuropeForxigaPharmaceuticalPricingRegulation

AstraZeneca to buy Omthera in up to $443 million deal

28-05-2013

Anglo-Swedish drug major AstraZeneca's (LSE: AZN) new chief executive Pascal Soriot is making another…

AstraZenecaCardio-vascularEpanovaMergers & AcquisitionsOmthera PharmaceuticalsPharmaceutical

AstraZeneca plans to move three cancer drug candidates into Ph III

16-05-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) this morning (May 16) announced that it will be moving…

AstraZenecaBiotechnologyMedImmunemoxetumomab pasudotoxolaparibOncologyPharmaceuticalResearchselumetinib

BioCity to develop BioHub at Alderley Park post AstraZeneca

07-05-2013

BioCity Nottingham, a UK provider of life sciences business incubation services, has been appointed by…

AstraZenecaBiotechnologyEuropePharmaceuticalResearch

DC Circuit Court says AstraZeneca not entitled to three-year exclusivity for Seroquel

29-04-2013

In a brief opinion handed down last week by the US Court of Appeals for the District of Columbia Circuit,…

AstraZenecaNeurologicalNorth AmericaPatentsPharmaceuticalSeroquel

AstraZeneca sales and earning down in 1st-qtr 2013, as patent cliff bites

25-04-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has reported first-quarter 2013 financial results with…

AstraZenecaFinancialPharmaceutical

Alchemia in up to A$240 million deal with AstraZeneca for VAST discovery platform

23-04-2013

In a third drug discovery agreement in a matter of days, Anglo-Swedish drug major AstraZeneca (LSE: AZN)…

AlchemiaAstraZenecaLicensingPharmaceuticalResearch

Horizon Discovery signs cancer drug discovery deal with AstraZeneca

22-04-2013

In a second deal announced today (April 22), Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed…

AstraZenecaHD-001Horizon DiscoveryLicensingOncologyPharmaceuticalResearch

Japan Supreme Court absolves AstraZeneca over deaths associated with Iressa

17-04-2013

The Japanese Supreme Court has upheld high court rulings that the Japanese unit of Anglo-Swedish drug…

Asia-PacificAstraZenecaIressaLegalOncologyPharmaceutical

Briefs: Royalty sweetens offer for Elan; AstraZeneca biomarker deal

16-04-2013

US private equity company Royalty Pharma today (April 15) issued a firm improved takeover offer for Ireland-based…

AstraZenecaElanLicensingMergers & AcquisitionsOncologyOxford Cancer BiomarkersPharmaceuticalResearchRoyalty Pharma

Mixed top-line results for AstraZeneca's RA drug candidate fostamatinib

05-04-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) this morning reported top-line results from the Phase…

Anti-Arthritics/RheumaticsAstraZenecafostamatinibPharmaceuticalResearch

AstraZeneca acquires AlphaCore; Merck Serono links with BioMed X

03-04-2013

In line with its stated policy of targeted acquisitions, Anglo-Swedish drug major AstraZeneca (LSE: AZN)…

AlphaCore PharmaAstraZenecaBiotechnologyCardio-vascularMerck KGaAMerck SeronoMergers & AcquisitionsMetabolicsPharmaceuticalResearch

Proposal to list AstraZeneca's Brilinta in New Zealand

26-03-2013

New Zealand's Pharmaceutical Management Agency, PHARMAC, is seeking feedback on a proposal to fund the…

Asia-PacificAstraZenecaBrilintaCardio-vascularFinancialHealthcarePharmaceuticalPricingticagrelor

Positive reception for AstraZeneca recovery strategy

22-03-2013

The marathon eight-hour strategy update presented in New York on Thursday (March 21) by AstraZeneca's…

AstraZenecaFinancialPharmaceuticalResearch

AstraZeneca entices GSK R&D exec to head its Global Portfolio & Product Strategy

21-03-2013

Troubled Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced that Marc Dunoyer is to join the company…

AstraZenecaManagementPharmaceutical

Major overhaul of AstraZeneca R&D sites, and HQ move, will see 1,600 job cuts

19-03-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN), which is struggling with recent research disappointments…

AstraZenecaFinancialManagementPharmaceuticalResearch

151 to 175 of 313 results

Back to top